The medicine 'Reaferon'. Instructions

The drug "Reaferon" (candles, powder) has an immunomodulatory, antitumor and antiviral effect. The powder is intended for the preparation of a solution for insertion into the muscle and topical application. The drug "Reaferon" (interferon alfa2a) has pyrogenic activity.

The drug is prescribed in complex therapy for adults with hepatitis B (acute viral) in severe and moderate forms at the beginning of icteric stage until the fifth day of jaundice, viral conjunctivitis, keratitis, keratoconjunctivitis, keratouveitis. The drug "Reaferon" instruction recommends with multiple sclerosis, hairy cell leukemia, kidney cancer of the fourth degree.

The drug is contraindicated in allergic pathologies (including polyvalent allergies), pregnancy, hypersensitivity. The agent "Reaferon" instruction does not allow for prescribing to patients in childhood.

Among the undesirable manifestations with the introduction of the drug should be noted pruritus, rashes on the skin, fever, fatigue, chills, thrombocytopenia, and leukopenia. The specified side reactions to the medicine "Reaferon" the instruction does not consider the reason, in connection with which it is necessary to stop treatment.

With local use of the drug, it is possible to develop edema, irritation, or conjunctival infection. The drug can cause the emergence of single follicles.

The drug "Reaferon" instruction recommends the administration of subconjunctival, intramuscular or local use.

For the injection into the muscle, the contents of the ampoule must be dissolved in a milliliter of NaCl solution of 0.9%.

When hepatitis B (acute) apply one million IU twice a day. This dose is administered five to six days. After the dosage is reduced to one million IU once a day and applied for another five days. After the control of biochemical parameters in the blood, if necessary, therapy is continued. The dosage of the drug "Reaferon" instruction at the same time recommends the installation of one million IU twice a week for two weeks. The amount of the drug for the therapeutic course is 15-20 million IU.

With cancer in the kidney, the "Reaferon" remedy is recommended for use in a dose of three million IU daily. Duration of treatment - ten days. If necessary, repeat therapy (three to nine or more courses) is carried out intermittently in three weeks. The total dosage per course is from ninety to two hundred and seventy million IU or more.

With hairy cell leukemia, the drug "Reaferon" is administered in an amount of three to six million IU (in accordance with individual tolerability) for two months. Supportive therapy is prescribed after the normalization of the hemogram. Dosage is recommended for three million IU twice a week for an extended period. The total dose for the course is 420-600 million IU or more.

With multiple sclerosis (scattered), one million IU is prescribed three times a day for pyramidal syndrome, once or twice a day - with cerebellar syndrome. Treatment is carried out for ten days. After a ten-day course, one million IU is administered once a week for five or six months. The total dose for the course is from fifty to sixty million IU.

Subconjunctival administration occurs with keratoridocyclitis and stromal keratitis in a dose of sixty thousand IU every other day or every day in accordance with the severity of the process. Injections are performed under local anesthesia with a 0.5% tetracaine solution. The duration of therapy is fifteen to twenty five injections.

Locally, the drug is dripped two drops six to eight times a day with superficial keratitis and conjunctivitis. Instillations are carried out in the affected eye. As the condition is eased, the number of injections is reduced to three to four per day. The duration of therapy is two weeks.

Before using the drug "Reaferon" you need to carefully study the annotation and consult with your doctor.